BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 26218737)

  • 41. Quantitative
    Lopez JM; Zimic M; Vallejos K; Sevilla D; Quispe-Carbajal M; Roncal E; Rodríguez J; Rodríguez J; Antiparra R; Arteaga H; Gilman RH; Maruenda H; Sheen P
    J Clin Microbiol; 2023 May; 61(5):e0152222. PubMed ID: 37071032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design.
    Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D
    J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is sequencing better than phenotypic tests for the detection of pyrazinamide resistance?
    Bouzouita I; Cabibbe AM; Trovato A; Draoui H; Ghariani A; Midouni B; Essalah L; Mehiri E; Cirillo DM; Slim-Saidi L
    Int J Tuberc Lung Dis; 2018 Jun; 22(6):661-666. PubMed ID: 29862951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran.
    Doustdar F; Khosravi AD; Farnia P
    Microb Drug Resist; 2009 Dec; 15(4):251-6. PubMed ID: 19857130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment outcomes in multidrug-resistant tuberculosis according to pyrazinamide susceptibility.
    Park S; Jo KW; Shim TS
    Int J Tuberc Lung Dis; 2020 Feb; 24(2):233-239. PubMed ID: 32127109
    [No Abstract]   [Full Text] [Related]  

  • 46. Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm.
    Simons SO; van der Laan T; Mulder A; van Ingen J; Rigouts L; Dekhuijzen PN; Boeree MJ; van Soolingen D
    Clin Microbiol Infect; 2014 Oct; 20(10):1015-20. PubMed ID: 24890253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. pncA mutations are associated with slower sputum conversion during standard treatment of multidrug-resistant tuberculosis.
    Zheng X; Ning Z; Drobniewski F; Yang J; Li Q; Zhang Z; Hu Y
    Int J Antimicrob Agents; 2017 Feb; 49(2):183-188. PubMed ID: 28012685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide.
    Daneau G; Gumusboga M; De Rijk P; Trebucq A; Rigouts L; Van Deun A; de Jong BC
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S46-S47. PubMed ID: 28043604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.
    Velásquez GE; Calderon RI; Mitnick CD; Becerra MC; Huang CC; Zhang Z; Contreras CC; Yataco RM; Galea JT; Lecca LW; Murray MB
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6766-6773. PubMed ID: 27600032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence, Transmission and Genetic Diversity of Pyrazinamide Resistance Among Multidrug-Resistant
    Liu B; Su P; Hu P; Yan M; Li W; Yi S; Chen Z; Zhang X; Guo J; Wan X; Wang J; Gong D; Bai H; Wan K; Liu H; Li G; Tan Y
    Infect Drug Resist; 2024; 17():403-416. PubMed ID: 38328339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru.
    Calderón RI; Velásquez GE; Becerra MC; Zhang Z; Contreras CC; Yataco RM; Galea JT; Lecca LW; Kritski AL; Murray MB; Mitnick CD
    Int J Tuberc Lung Dis; 2017 Aug; 21(8):894-901. PubMed ID: 28786798
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pyrazinamide-resistant Tuberculosis Obscured From Common Targeted Molecular Diagnostics.
    Modlin SJ; Mansjö M; Werngren J; Ejike CM; Hoffner SE; Valafar F
    Drug Resist Updat; 2023 May; 68():100959. PubMed ID: 37043916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience.
    Hoffner S; Angeby K; Sturegård E; Jönsson B; Johansson A; Sellin M; Werngren J
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1486-90. PubMed ID: 24125455
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterisation of the pncA gene in Mycobacterium tuberculosis isolates from Gauteng, South Africa.
    Bishop KS; Blumberg L; Trollip AP; Smith AN; Roux L; York DF; Kiepiela P
    Int J Tuberc Lung Dis; 2001 Oct; 5(10):952-7. PubMed ID: 11605890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene.
    Bhuju S; Fonseca Lde S; Marsico AG; de Oliveira Vieira GB; Sobral LF; Stehr M; Singh M; Saad MH
    Infect Genet Evol; 2013 Oct; 19():1-6. PubMed ID: 23770140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium Tuberculosis.
    Shi D; Zhou Q; Xu S; Zhu Y; Li H; Xu Y
    Infect Drug Resist; 2022; 15():4985-4994. PubMed ID: 36065280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Park J; Shin SY; Kim K; Park K; Shin S; Ihm C
    Ann Lab Med; 2018 Jul; 38(4):316-323. PubMed ID: 29611381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
    Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
    BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates.
    Huy NQ; Lucie C; Hoa TTT; Hung NV; Lan NTN; Son NT; Nhung NV; Anh DD; Anne-Laure B; Van Anh NT
    Emerg Microbes Infect; 2017 Oct; 6(10):e86. PubMed ID: 29018250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estimation of pyrazinamidase activity using a cell-free
    Rueda D; Bernard C; Gandy L; Capton E; Boudjelloul R; Brossier F; Veziris N; Zimic M; Sougakoff W
    Int J Mycobacteriol; 2018; 7(1):16-25. PubMed ID: 29516881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.